5d 1m 3m 1y 5y 10y
There are 3 articles on this stock available only to PRO subscribers.
Marketwire (Mar 31, 2014)
Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for Probuphine Clinical StudyMarketwire (Mar 3, 2014)
TTNP vs. ETF Alternatives
Titan Pharmaceuticals, Inc is a biopharmaceutical company focused in the development of products for the treatment of central nervous system (CNS) diseases.
Country: United States